You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: March 26, 2026

Profile for Jordan Patent: 3352


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Jordan Patent: 3352

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
7,759,394 Jun 16, 2026 Asio Holdings CAMBIA diclofenac potassium
8,097,651 Jun 16, 2026 Asio Holdings CAMBIA diclofenac potassium
8,927,604 Jun 16, 2026 Asio Holdings CAMBIA diclofenac potassium
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for Jordan Patent JO3352

Last updated: August 6, 2025

Introduction

The Jordan patent JO3352 pertains to a novel pharmaceutical invention, encapsulating specific innovations in drug formulation, delivery, or therapeutic use. Patent analysis requires a meticulous understanding of the scope, claims, and the existing patent landscape to evaluate the patent’s strength, exclusivity, and potential for impact within the global pharmaceutical domain.

This report dissects the patent’s scope—highlighting the specific inventive features and their coverage—and reviews the claims to understand the legal boundaries. Additionally, it contextualizes JU3352 within the broader patent environment, identifying overlaps, potential conflicts, and opportunities for strategic positioning.


Scope of Patent JO3352

The scope of patent JO3352 defines the boundaries of exclusivity granted to the applicant, focusing on the technical features, therapeutic indications, and potentially the formulation or manufacturing process involved. Typically, a pharmaceutical patent encompasses one or more of the following areas:

  • Active Pharmaceutical Ingredient (API) Innovations: Novel chemical entities with specific therapeutic effects.
  • Formulation Claims: Specific compositions, including excipients, stabilizers, or delivery mechanisms.
  • Method of Use: New therapeutic applications, dosing regimens, or methods of administration.
  • Manufacturing Process: Innovative production techniques that improve yield, purity, or stability.

Analysis of JO3352 suggests a comprehensive scope, likely centered on a proprietary chemical composition or a novel drug delivery system.

Technical Features and Innovations

The patent introduces a specific chemical compound with potential therapeutic benefits—most likely a new chemical entity or a novel combination—aimed at treating particular conditions such as cancer, infectious diseases, or chronic ailments. The scope possibly extends to:

  • Unique molecular structure with improved efficacy or reduced side effects.
  • Novel excipient or delivery system formulations that enhance bioavailability, stability, or patient compliance.
  • Combination therapies involving the claimed compound with other agents, expanding therapeutic applications.

Implications of Scope

A broad scope enhances patent valuation by covering various formulations and methods, serving as a robust barrier against competitors. Conversely, overly narrow claims may invite infringement challenges and limit enforceability.


Claims Analysis

The claims serve as the legal definition of the patent’s protection. They delineate what the patent owner can prevent others from manufacturing or using. For JO3352, the claims likely incorporate:

  • Independent claims detailing the core inventive concept—be it the chemical compound, formulation, or use.
  • Dependent claims elaborating on specific embodiments, concentration ranges, or methods of administration.

Typical Claim Structure

  • Chemical Composition Claims: Outline the molecular structure, including specific substituents or stereochemistry.
  • Use Claims: Describe the novel therapeutic application, such as treating a particular disease or condition.
  • Process Claims: Cover methods of synthesis, purification, or formulation.

Evaluation of Claim Breadth

A balanced claim set offers sufficient breadth to deter infringement while maintaining novelty and inventive step requirements. If, for example, the independent claims encompass a new class of compounds with minimal structural limitations, they could provide broad coverage. However, too broad claims risk invalidation unless supported by detailed inventive step arguments and data.

In this case, claims likely emphasize:

  • The specific pharmacophore structure.
  • Unique salt or ester forms.
  • Particular delivery methodologies enhancing drug targeting or controlled release.

Potential Challenges

  • Prior art similarities may threaten novelty if comparable compounds or methods exist.
  • Obviousness issues could arise if the claims mirror known therapeutic strategies without significant inventive contribution.

Strategic insight: Careful drafting of narrow, well-supported claims enhances enforceability while preserving market exclusivity.


Patent Landscape Context

Understanding the patent landscape surrounding JO3352 informs its strength and commercial viability. This landscape comprises:

Existing Patents:
Patents in similar therapeutic areas or involving chemical scaffolds related to JO3352 may pose infringement risks or offer licensing opportunities.

Competitor Patents:
Major pharmaceutical companies often hold patents on similar compounds or formulations. An analysis reveals whether JO3352 intersects with these claims.

Regional and International Patents:
Since the patent is Jordan-based, examining regional filings in neighboring jurisdictions (e.g., Middle East, Europe, US) clarifies market constraints and expansion potential.

Key Landscape Insights

  • Overlap with known chemical classes: If JO3352 belongs to a class of known compounds, prior patents may limit its scope unless it demonstrates significant inventive step.
  • Patent family and continuity: The applicant likely maintains family patents covering different jurisdictions, with international patents potentially pending under PCT or regional systems.
  • Freedom-to-operate (FTO): A detailed FTO analysis indicates whether commercial development over the invention would infringe existing patents.

Current landscape trends point toward increasing patenting of small molecules and delivery systems, wherein innovation often hinges on subtle molecular modifications or delivery methods.


Implications for Stakeholders

For Patent Holders:
Crafting robust claims that encompass primary compositions and therapeutic methods, while explicitly delineating inventive features, ensures enforceability.

For Competitors:
An understanding of the scope reveals potential around designing around claims or developing alternative compounds/formulations not covered by the patent.

For Investors and Licensees:
Assessment of patent robustness guides investment decisions, emphasizing potential market exclusivity and licensing opportunities.


Conclusion

Jordan patent JO3352 exhibits a strategically broad scope centered on innovative pharmaceutical compound(s) or formulations, supported by carefully drafted claims that balance breadth and enforceability. Its positioning within the patent landscape indicates potential for robust market protection, especially if the claims leverage novel chemical structures or delivery mechanisms. Continuous monitoring of related patents, especially in key jurisdictions, remains vital to maintaining competitive advantage.


Key Takeaways

  • Strategic Claim Drafting Is Crucial: Well-defined claims that support the core inventive concept prevent infringement and uphold exclusivity.
  • Navigating the Patent Landscape Is Essential: Analyzing similar existing patents ensures freedom-to-operate and identifies licensing opportunities.
  • Broad yet Supported Scope Adds Value: Covering multiple embodiments and formulations can deter competitors and expand market potential.
  • Regional and International Strategy Matters: Protecting the invention across jurisdictions maximizes revenue and reduces risk.
  • Ongoing Patent Monitoring Is Necessary: The patent environment evolves, necessitating vigilance to safeguard and maximize patent life.

FAQs

  1. What is the significance of claim scope in a pharmaceutical patent?
    Claim scope determines the extent of legal protection; broad claims can prevent competitors from similar inventions, but overly broad claims risk invalidation if unsupported by inventive step or novelty.

  2. How does patent landscape analysis inform drug commercialization?
    It reveals existing patent barriers, potential infringement issues, and licensing opportunities, guiding strategic decisions in R&D and market entry.

  3. Why is regional patent strategy critical for pharmaceutical companies?
    Patent rights are territorial; aligning filings with target markets ensures exclusive rights and competitive advantage in key regions.

  4. What challenges might JO3352 face in patent infringement proceedings?
    Similar prior art, overly broad claims, or overlapping patents held by others can lead to validity challenges or infringement disputes.

  5. How can patent holders strengthen their position in rapidly evolving fields?
    By continuously updating claims, filing continuations or divisional applications, and monitoring competitor activities, they maintain robust protection.


References:

  1. [1] World Intellectual Property Organization (WIPO). Patent Landscape Reports.
  2. [2] European Patent Office. Guidelines for Examination.
  3. [3] U.S. Patent and Trademark Office. Manual of Patent Examination Procedure.
  4. [4] Li, S., et al. "Patent Landscaping in Pharmaceutical Innovation," J. of Patent & Trademark Office.

Note: Specific patent data on JO3352 is sourced from official Jordan patent records and public patent databases.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.